lobbying_filings_raw: d15869e2-bfcd-4dfa-8a89-eab28aa0fa78

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json
d15869e2-bfcd-4dfa-8a89-eab28aa0fa78 Q3 25328 DENNY MILLER ASSOCIATES 133018 CELL THERAPEUTICS 2012 third_quarter 2012-10-15T13:55:42.557000-04:00 30000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/d15869e2-bfcd-4dfa-8a89-eab28aa0fa78/", "filing_uuid": "d15869e2-bfcd-4dfa-8a89-eab28aa0fa78", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2012, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/d15869e2-bfcd-4dfa-8a89-eab28aa0fa78/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Denny Miller, President", "dt_posted": "2012-10-15T13:55:42.557000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "400 N Capitol St, NW Suite 363", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 25328, "url": "https://lda.senate.gov/api/v1/registrants/25328/", "house_registrant_id": 30761, "name": "DENNY MILLER ASSOCIATES", "description": "Lobbying, consulting and government relations", "address_1": "400 N Capitol St, Ste 363", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20001", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MELISSA BROWN", "contact_telephone": "+1 202-783-0280", "dt_updated": "2022-04-06T16:06:34.952708-04:00"}, "client": {"id": 133018, "url": "https://lda.senate.gov/api/v1/clients/133018/", "client_id": 48, "name": "CELL THERAPEUTICS", "general_description": null, "client_government_entity": false, "client_self_select": null, "state": "WA", "state_display": "Washington", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-07-30"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "European Union approval of US cancer drugs.", "foreign_entity_issues": "Italian Embassy.", "lobbyists": [{"lobbyist": {"id": 50262, "prefix": null, "prefix_display": null, "first_name": "JUDSON", "nickname": null, "middle_name": null, "last_name": "GREIF", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 12626, "prefix": "ms", "prefix_display": "MS.", "first_name": "SANDRA", "nickname": null, "middle_name": null, "last_name": "MATHIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 13388, "prefix": null, "prefix_display": null, "first_name": "WILL", "nickname": null, "middle_name": null, "last_name": "STONE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 50262, "prefix": null, "prefix_display": null, "first_name": "JUDSON", "nickname": null, "middle_name": null, "last_name": "GREIF", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 12626, "prefix": "ms", "prefix_display": "MS.", "first_name": "SANDRA", "nickname": null, "middle_name": null, "last_name": "MATHIESEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []}

Links from other tables